Fig. 2

Association between final outcome and absolute counts of circulating CD14^pos/HLA-DR^pos/CD45^pos monocytes. a Absolute counts of CD14^pos/HLA-DR^pos/CD45^pos monocytes of survivors and nonsurvivors on days 1 and 3 and healthy volunteers. P values refer to comparisons between survivors and nonsurvivors. b ROC curve of the absolute count of CD14^pos/HLA-DR^pos/CD45^pos monocytes on day 1 to predict survival after 28 days. c Predictive value of an absolute count of CD14^pos/HLA-DR^pos/CD45^pos monocytes more than 337 cells/mm³ on day 1 for survival after 28 days. d) Comparative survival in relation to the absolute count of CD14^pos/HLA-DR^pos/CD45^pos monocytes on day 1. AUC area under curve, CI confidence interval, NPV negative predictive value, PPV positive predictive value, Sens sensitivity, Spec specificity